Jubilant Pharmova Limited Asset Resilience Ratio

Latest as of March 2025: 1.26%

Jubilant Pharmova Limited asset resilience ratio. Jubilant Pharmova Limited (JUBLPHARMA) has an Asset Resilience Ratio of 1.26% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Jubilant Pharmova Limited for a breakdown of total debt and financial obligations.

Liquid Assets

Rs1.61 Billion

≈ $17.41 Million USD Cash + Short-term Investments

Total Assets

Rs127.56 Billion

≈ $1.38 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Jubilant Pharmova Limited (2013–2025)

Asset resilience ratio of Jubilant Pharmova Limited from 2013 to 2025. This chart shows how Jubilant Pharmova Limited's Asset Resilience Ratio has changed over time. See Jubilant Pharmova Limited (JUBLPHARMA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Jubilant Pharmova Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Jubilant Pharmova Limited.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs1.61 Billion	1.26%
Total Liquid Assets	Rs1.61 Billion	1.26%

Asset Resilience Insights

Limited Liquidity: Jubilant Pharmova Limited maintains only 1.26% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jubilant Pharmova Limited Industry Peers by Asset Resilience Ratio

Compare Jubilant Pharmova Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Laurus Labs Limited NSE:LAURUSLABS	Drug Manufacturers - Specialty & Generic	0.74%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	9.44%
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	Drug Manufacturers - Specialty & Generic	1.37%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	3.47%
Zhejiang Tianyu Pharmaceutical Co Ltd SHE:300702	Drug Manufacturers - Specialty & Generic	0.02%
Procter & Gamble Health Limited NSE:PGHL	Drug Manufacturers - Specialty & Generic	33.01%

Jubilant Pharmova Limited Asset Resilience Ratio by Year (2013–2025)

Jubilant Pharmova Limited asset resilience ratio by year from 2013 to 2025. The table below shows the annual Asset Resilience Ratio data for Jubilant Pharmova Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.00%	Rs5.00 Million ≈ $54.07K	Rs127.56 Billion ≈ $1.38 Billion	+0.00pp
2024-03-31	0.00%	Rs4.00 Million ≈ $43.26K	Rs115.48 Billion ≈ $1.25 Billion	+0.00pp
2023-03-31	0.00%	Rs3.84 Million ≈ $41.53K	Rs111.57 Billion ≈ $1.21 Billion	-0.05pp
2022-03-31	0.05%	Rs53.53 Million ≈ $578.91K	Rs99.91 Billion ≈ $1.08 Billion	-2.05pp
2021-03-31	2.10%	Rs1.87 Billion ≈ $20.27 Million	Rs89.18 Billion ≈ $964.46 Million	+0.61pp
2020-03-31	1.50%	Rs1.87 Billion ≈ $20.27 Million	Rs125.22 Billion ≈ $1.35 Billion	-1.79pp
2019-03-31	3.29%	Rs3.77 Billion ≈ $40.77 Million	Rs114.69 Billion ≈ $1.24 Billion	+2.98pp
2018-03-31	0.31%	Rs294.56 Million ≈ $3.19 Million	Rs96.18 Billion ≈ $1.04 Billion	+0.15pp
2017-03-31	0.16%	Rs144.88 Million ≈ $1.57 Million	Rs90.41 Billion ≈ $977.71 Million	+0.10pp
2016-03-31	0.06%	Rs53.16 Million ≈ $574.91K	Rs89.47 Billion ≈ $967.59 Million	-0.02pp
2015-03-31	0.08%	Rs66.49 Million ≈ $719.06K	Rs86.32 Billion ≈ $933.54 Million	+0.01pp
2014-03-31	0.07%	Rs57.63 Million ≈ $623.25K	Rs88.61 Billion ≈ $958.24 Million	+0.02pp
2013-03-31	0.05%	Rs40.53 Million ≈ $438.32K	Rs84.32 Billion ≈ $911.89 Million	--

pp = percentage points

About Jubilant Pharmova Limited

NSE:JUBLPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$1.60 Billion

Rs148.22 Billion INR

Market Cap Rank

#6849 Global

#324 in India

Share Price

Rs935.80

Change (1 day)

-0.30%

52-Week Range

Rs807.65 - Rs1181.20

All Time High

Rs1269.00